ZEB1 and colorectal cancer: Similarly, an increasing number of studies support the belief that ZEB1-AS1 might be attributed to a poor prognosis in GC [19], colorectal cancer [53], gliomas [17], esophageal squamous cell carcinoma [18], and hepatocellular carcinoma [16].